These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9483185)
1. Long-term follow-up of carotid atherosclerosis in patients with heterozygous familial hypercholesterolemia under LDL apheresis treatment. Donner MG; Richter WO; Schwandt P J Clin Apher; 1997; 12(4):202-3. PubMed ID: 9483185 [No Abstract] [Full Text] [Related]
2. Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis. Mabuchi H; Koizumi J; Michishita I; Takeda M; Kajinami K; Fujita H; Inazu A; Uno Y; Shimizu M; Takeda R Beitr Infusionsther; 1988; 23():87-96. PubMed ID: 2484787 [No Abstract] [Full Text] [Related]
3. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia. Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients. Koga N; Watanabe K; Kurashige Y; Sato T; Hiroki T J Intern Med; 1999 Jul; 246(1):35-43. PubMed ID: 10447223 [TBL] [Abstract][Full Text] [Related]
5. LDL-apheresis improves microalbuminuria in patients with severe familial heterozygous hypercholesterolemia. Sinzinger H; Kritz H Atherosclerosis; 1999 Mar; 143(1):223-4. PubMed ID: 10208501 [No Abstract] [Full Text] [Related]
6. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia. Koga N Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750 [TBL] [Abstract][Full Text] [Related]
7. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502 [TBL] [Abstract][Full Text] [Related]
8. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group. Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308 [TBL] [Abstract][Full Text] [Related]
9. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns]. Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282 [TBL] [Abstract][Full Text] [Related]
10. [Atheromatous carotid artery changes in familial hypercholesterolemia before and following therapy]. Spengel FA; Keller C Vasa Suppl; 1991; 33():52-4. PubMed ID: 1788761 [No Abstract] [Full Text] [Related]
11. Long term effect of LDL apheresis on coronary heart disease. Donner MG; Richter WO; Schwandt P Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655 [TBL] [Abstract][Full Text] [Related]
12. Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapy. Jacob BG; Richter WO; Schwandt P Clin Investig; 1993 Nov; 71(11):908-12. PubMed ID: 8312683 [TBL] [Abstract][Full Text] [Related]
13. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis. Jones PH Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769 [No Abstract] [Full Text] [Related]
14. Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levels. Ritter MM; Sühler K; Richter W; Schwandt P Clin Chim Acta; 1990 Dec; 195(1-2):9-15. PubMed ID: 2151209 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053 [TBL] [Abstract][Full Text] [Related]
16. [LDL apheresis in the treatment of hyperlipoproteinemia]. Ishikawa K Nihon Rinsho; 1994 Dec; 52(12):3298-302. PubMed ID: 7853726 [TBL] [Abstract][Full Text] [Related]
17. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001. Krebs A; Krebs K; Keller F Int J Artif Organs; 2004 Feb; 27(2):137-48. PubMed ID: 15061475 [TBL] [Abstract][Full Text] [Related]
18. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia. Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324 [TBL] [Abstract][Full Text] [Related]
19. Advances in LDL-apheresis for the treatment of severe hypercholesterolemia. Gordon BR; Saal SD Curr Opin Lipidol; 1994 Feb; 5(1):69-73. PubMed ID: 15559033 [TBL] [Abstract][Full Text] [Related]
20. Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline664 to leucine mutation. Takahashi K; Kobayashi J; Bujo H; Takahashi M; Taira K; Kaneko K; Tashiro J; Shinomiya M; Miyazaki A; Saito Y Intern Med; 2000 Oct; 39(10):804-9. PubMed ID: 11030204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]